Report: Cancer Research Institute's 2025 Cancer Immunotherapy Insights and Impact
The inaugural Cancer Immunotherapy Insights and Impact Report is a comprehensive, data‑driven analysis of FDA immunotherapy approvals, clinical utilization trends, and the future of precision immuno‑oncology.
Cancer Research Institute’s first comprehensive, data-driven look at the trajectory of cancer immunotherapy traces the evolution of the field from 2011 through the end of 2024. The goal of the report is to equip the field with a rigorous synthesis of regulatory trends, mechanistic advances, and clinical utilization, in order to track how the field is progressing and where it is heading.
To read the full report, click here.
